Conavi Medical Corp. Conavi Medical Corp.

Conavi Medical Corp.

CNVIF

Rang in Aktien #33308
Conavi Medical Corp. is a medical technology firm that specializes in... Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Aktienkurs
$0.088
Marktkapitalisierung
$7.51M
Veränderung (1 Tag)
-11.65%
Veränderung (1 Jahr)
-89.24%
Land
CA
Handel Conavi Medical Corp. (CNVIF)

Kategorie

Healthcare
P/B-Verhältnis für Conavi Medical Corp. (CNVIF)
P/B-Verhältnis zum October 2026 TTM: 20.06
Laut den neuesten Finanzberichten und dem Aktienkurs von Conavi Medical Corp. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 20.06. Am Ende des Jahres 2022 lag das P/B-Verhältnis bei -585.04.
P/B-Verlauf für Conavi Medical Corp. von 2007 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 20.06 -43.70%
2023 35.64 -106.09%
2022 -585.04 -1,300.42%
2021 48.74 -123.59%
2020 -206.59 531.03%
2019 -32.74 -126.81%
2018 122.13 -31.89%
2017 179.31 -87.76%
2016 1.47K -130.78%
2015 -4.76K -5,081.41%
2014 95.57 -87.72%
2013 778.02 86.70%
2012 416.73 112.61%
2011 196.01 18.27%
2010 165.73 55.49%
2009 106.59 30.66%
2008 81.57 -89.18%
2007 753.59 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
3.5116 -82.50%
US
2.0146 -89.96%
IE
4.5025 -77.56%
US
2.5486 -87.30%
US
- -
DE